Brain cancers, mainly high-grade gliomas/glioblastoma, are characterized by uncontrolled
proliferation and recurrence with an extremely poor prognosis. Despite various conventional …

Malignant brain tumors remain to be highly fatal illnesses with a bleak outlook, as the
average survival rate for patients after receiving medical treatment is less than two years …

Glioblastoma multiforme is the most common and aggressive malignant tumor that affects
the central nervous system, with high mortality and low survival. Glioblastoma multiforme …

Glioblastoma (GBM) is an aggressive, fatal and malignant primary brain tumor. Despite the
current standard treatment for glioblastoma patients including neurosurgical resection …

Malignant brain tumor is a life-threatening disease with a low survival rate. The therapies
available for the treatment of brain tumor is limited by poor uptake via the blood–brain …

Translation of novel therapies for brain cancer into clinical practice is of the utmost
importance as primary brain tumors are responsible for more than 200,000 deaths …

Malignant gliomas are one of the deadliest forms of brain cancer and despite advancements
in treatment, patient prognosis remains poor, with an average survival of 15 months …

Simple Summary Brain metastases are amongst the most invasive and lethal cancers. Yet,
effective methods for their diagnosis and therapy have remained elusive. While several …

The most common malignant tumor of the brain is glioblastoma multiforme (GBM) in adults.
Many patients die shortly after diagnosis, and only 6% of patients survive more than 5 years …

Malignant brain cancer treatment is limited by a number of barriers, including the blood–
brain barrier, transport within the brain interstitium, difficulties in delivering therapeutics …